These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 33193571)

  • 1. Identification and Validation of an Immunological Expression-Based Prognostic Signature in Breast Cancer.
    Pei J; Li Y; Su T; Zhang Q; He X; Tao D; Wang Y; Yuan M; Li Y
    Front Genet; 2020; 11():912. PubMed ID: 33193571
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification and validation of a novel prognostic signature based on transcription factors in breast cancer by bioinformatics analysis.
    Yang Y; Li Z; Zhong Q; Zhao L; Wang Y; Chi H
    Gland Surg; 2022 May; 11(5):892-912. PubMed ID: 35694087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of a prognostic score model for breast cancer based on multi-omics analysis of study on bone metastasis.
    Ren H; Shen X; Xie M; Guo X
    Transl Cancer Res; 2024 May; 13(5):2419-2436. PubMed ID: 38881940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a pyroptosis-related prognostic signature in breast cancer.
    Chen H; Luo H; Wang J; Li J; Jiang Y
    BMC Cancer; 2022 Apr; 22(1):429. PubMed ID: 35443644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using immune-related lncRNAs to construct novel biomarkers and investigate the immune landscape of breast cancer.
    Qin M; Ma Y; Wang Z; Fang D; Wei J
    Transl Cancer Res; 2021 Jun; 10(6):2991-3003. PubMed ID: 35116607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of a N1-methyladenosine-related risk signature for breast carcinoma by bioinformatics analysis and experimental validation.
    Li L; Yang W; Jia D; Zheng S; Gao Y; Wang G
    Breast Cancer; 2023 Jul; 30(4):666-684. PubMed ID: 37178414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a Transcription Factor Signature That Can Predict Breast Cancer Survival.
    Fan C; Du J; Liu N
    Comput Math Methods Med; 2021; 2021():2649123. PubMed ID: 33688372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic and immune implications of a novel 7-methylguanosine-related microRNA signature in breast invasive carcinoma: from exploration to validation.
    Li AY; Xiao HN; Zhao ZY; Xiang C; Chen ZY; Wang PX; Xia Y; Yu B; Li H; Xiao T
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):9105-9128. PubMed ID: 37171615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network.
    Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D
    Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Immune-Related Long Noncoding RNA Pair as a New Biomarker to Predict the Prognosis of Patients in Breast Cancer.
    Jiang H; Sun J; Liu F; Wu X; Wen Z
    Front Genet; 2022; 13():895200. PubMed ID: 35812755
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification and Validation of a Novel Immune-Related Four-lncRNA Signature for Lung Adenocarcinoma.
    Wang J; Yin X; Zhang YQ; Ji X
    Front Genet; 2021; 12():639254. PubMed ID: 33708243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 17-gene expression-based prognostic signature associated with the prognosis of patients with breast cancer: A STROBE-compliant study.
    Qian JX; Yu M; Sun Z; Jiang AM; Long B
    Medicine (Baltimore); 2020 Apr; 99(15):e19255. PubMed ID: 32282693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Signature Integrated of Immunoglobulin, Glycosylation and Anti-Viral Genes to Predict Prognosis for Breast Cancer.
    Xu S; Liu Y; Ma H; Fang S; Wei S; Li X; Lu Z; Zheng Y; Liu T; Zhu X; Xu D; Pan Y
    Front Genet; 2022; 13():834731. PubMed ID: 35432482
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification and validation of a five-gene prognostic signature based on bioinformatics analyses in breast cancer.
    Du XJ; Yang XR; Wang QC; Lin GL; Li PF; Zhang WF
    Heliyon; 2023 Feb; 9(2):e13185. PubMed ID: 36747547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The therapeutic effect and targets of
    Yuan J; Lin M; Yang S; Yin H; Ouyang S; Xie H; Tang H; Ou X; Zeng Z
    Heliyon; 2024 May; 10(10):e31137. PubMed ID: 38778969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and validation of a novel zinc finger protein-related gene-based prognostic model for breast cancer.
    Ye M; Li L; Liu D; Wang Q; Zhang Y; Zhang J
    PeerJ; 2021; 9():e12276. PubMed ID: 34721975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A seven-nuclear receptor-based prognostic signature in breast cancer.
    Wu F; Chen W; Kang X; Jin L; Bai J; Zhang H; Zhang X
    Clin Transl Oncol; 2021 Jul; 23(7):1292-1303. PubMed ID: 33210236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive research into prognostic and immune signatures of transcription factor family in breast cancer.
    Wu Q; Zheng S; Lin N; Xie X
    BMC Med Genomics; 2023 Apr; 16(1):87. PubMed ID: 37098532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A glycolysis-related signature to improve the current treatment and prognostic evaluation for breast cancer.
    Feng S; Ning L; Zhang H; Wang Z; Lu Y
    PeerJ; 2024; 12():e17861. PubMed ID: 39119106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysing a Novel RNA-Binding-Protein-Related Prognostic Signature Highly Expressed in Breast Cancer.
    Lan Y; Su J; Xue Y; Zeng L; Cheng X; Zeng L
    J Healthc Eng; 2021; 2021():9174055. PubMed ID: 34707800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.